Novel pharmacological approaches to treatment of drug overdose and addiction

References

• Landry DW. Immunotherapy for cocaine addiction. Sci. Am.276, 42–45 (1997).
   Google Scholar
• Gorelick DA. Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy. Drug Alcohol. Depend.48, 159–165 (1997).
   PubMed Web of Science ®Google Scholar
• Redish AD. Addiction as a computational process gone awry. Science306, 1944–1947 (2004).
   PubMed Web of Science ®Google Scholar
• Gorelick DA, Gardner EL, Xi ZX. Agents in development for the management of cocaine abuse. Drugs64, 1547–1573 (2004).
   PubMed Web of Science ®Google Scholar
• Baird TJ, Deng SX, Landry DW, Winger G, Woods JH. Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats. J. Pharmacol. Exp. Ther.295, 1127–1134 (2000).
   PubMed Web of Science ®Google Scholar
• Deng SX, de Prada P, Landry DW. Anticocaine catalytic antibodies. J. Immunol. Methods269, 299–310 (2002).
   PubMed Web of Science ®Google Scholar
• Carrera MR,A, Ashley JA, Parsons LH, Wirsching P, Koob GF, Janda KD. Suppression of psychoactive effects of cocaine by active immunization. Nature378, 727–730 (1995).
   PubMed Web of Science ®Google Scholar
• Landry DW, Yang GX-Q. Anti-cocaine catalytic antibodies – a novel approach to the problem of addiction. J. Addict. Diseases16, 1–17 (1997).
   PubMed Web of Science ®Google Scholar
• Landry DW, Zhao K, Yang GX-Q, Glickman M, Georgiadis TM. Antibody catalyzed degradation of cocaine. Science259, 1899–1901 (1993).
   PubMed Web of Science ®Google Scholar
• Poet TS, McQueen CA, Halpert JR. Participation of cytochromes P4502B and P4503A in cocaine toxicity in rat hepatocytes. Drug Metab. Dispos.24, 74–80 (1996).
   PubMed Web of Science ®Google Scholar
• Pan W-J, Hedaya MA. Cocaine and alcohol interactions in the rat: contribution of cocaine metabolites to the pharmacological effects. J. Pharm. Sci.88, 468–476 (1999).
   Google Scholar
• Sukbuntherng J, Martin DK, Pak Y, Mayersohn M. Characterization of the properties of cocaine in blood: blood clearance, blood to plasma ratio, and plasma protein binding. J. Pharm. Sci.85, 567–571 (1996).
   Google Scholar
• Lockridge O, Blong RM, Masson P, Froment, M-T, Millard CB, Broomfield CA. A single amino acid substitution, Gly117His, confers phosphotriesterase (organophosphorus acid anhydride hydrolase) activity on human butyrylcholinesterase. Biochemistry36, 786–795 (1997).
   PubMed Web of Science ®Google Scholar
• Bresler MM, Rosser SJ, Basran A, Bruce NC. Gene cloning and nucleotide sequencing and properties of a cocaine esterase from Rhodococcus sp. strain MB1. Appl. Environ. Microbiol.66, 904–908 (2000).
   PubMed Web of Science ®Google Scholar
• Cooper ZD, Narasimhan D, Sunahara RK et al. Rapid and robust protection against cocaine-induced lethality in rats by the bacterial cocaine esterase. Mol. Pharmacol.70, 1885–1891 (2006).
   PubMed Web of Science ®Google Scholar
• Ko MC, Bowen LD, Narasimhan D et al. Cocaine esterase: interactions with cocaine and immune responses in mice. J. Pharmacol. Exp. Therap.320, 926–933 (2007).
   PubMedGoogle Scholar
• Gao D, Narasimhan DL, Macdonald J et al. Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol. Pharmacol. (2008) (Epub ahead of print).
   Google Scholar
• Gao D, Zhan C-G. Modeling evolution of hydrogen bonding and stabilization of transition states in the process of cocaine hydrolysis catalyzed by human butyrylcholinesterase. Proteins62, 99–110 (2006).
   PubMedGoogle Scholar
• Gao D, Zhan C-G. Modeling effects of oxyanion hole on the ester hydrolyses catalyzed by human cholinesterases. J. Phys. Chem. B109, 23070–23076 (2005).
   Google Scholar
• Zhan C-G, Deng S-X, Skiba JG et al. First-principle studies of intermolecular and intramolecular catalysis of protonated cocaine. J. Comput. Chem.26, 980–986 (2005).
   Google Scholar
• Gao D, Cho H, Yang W et al. Computational design of a human butyrylcholinesterase mutant for accelerating cocaine hydrolysis based on the transition-state simulation. Angew. Chem. Int. Ed.45, 653–657 (2006).
   Google Scholar
• Zhan C-G, Zheng F, Landry DW. Fundamental reaction mechanism for cocaine metabolism in human butyrylcholinesterase. J. Am. Chem. Soc.125, 2462–2474 (2003).
   PubMed Web of Science ®Google Scholar
• Zhan C-G, Gao D. Catalytic mechanism and energy barriers for butyrylcholinesterase-catalyzed hydrolysis of cocaine. Biophys. J.89, 3863–3872 (2005).
   PubMed Web of Science ®Google Scholar
• Hamza A, Cho H, Tai H-H, Zhan C-G. Molecular dynamics simulation of cocaine binding with human butyrylcholinesterase and its mutants. J. Phys. Chem. B109, 4776–4782 (2005).
   Google Scholar
• Pan Y, Gao D, Yang W et al. Computational redesign of human butyrylcholinesterase for anti-cocaine medication. Proc. Natl Acad. Sci. USA102, 16656–16661 (2005).
   PubMed Web of Science ®Google Scholar
• Pan Y, Gao D, Yang W, Cho H, Zhan C-G. Free energy perturbation (FEP) simulation on the transition-states of cocaine hydrolysis catalyzed by human butyrylcholinesterase and its mutants. J. Am. Chem. Soc.129, 13537–13543 (2007).
   Google Scholar
• Zheng F, Yang W, Ko M-C et al. Most efficient cocaine hydrolase designed by virtual screening of transition States. J. Am. Chem. Soc.130, 12148–12155 (2008).
   Google Scholar
• Brimijoin S, Gao Y, Anker JJ et al. A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats. Neuropsychopharmacology33, 2715–2725 (2008).
   PubMed Web of Science ®Google Scholar